Effects of continuous angiotensin I-converting enzyme blockade on blood pressure, sympathetic activity and renin-angiotensin system in stroke-prone spontaneously hypertensive rats.
D000803:Angiotensin I / Q000378:metabolism*; D000804:Angiotensin II / Q000378:metabolism* / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins / Q000378:metabolism*; D000818:Animals; D001794:Blood Pressure; D002216:Captopril / Q000494:pharmacology; D004198:Disease Susceptibility; D006973:Hypertension / Q000503:physiopathology*; D008297:Male; D009638:Norepinephrine / Q000097:blood / Q000494:pharmacology; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D051381:Rats; D012083:Renin / Q000097:blood / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D000804:Angiotensin II; D000803:Angiotensin I; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D012083:Renin; D009638:Norepinephrine